No effect of oral polio vaccine administered at birth on mortality and immune response to BCG: A natural experiment

Vaccine

Volumn 30, Issue 47, 2012, Pages 6694-6699

  Lund, Najaaraq ^a,b   Andersen, Andreas ^a   Monteiro, Ivan ^c   Aaby, Peter ^c   Benn, Christine Stabell ^a  

^a STATENS SERUM INSTITUT   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c Iganga Mayuge Health and Demographic Surveillance Site   (Guinea-Bissau)

Author keywords

Infant mortality; Neonate; Non specific effect; Oral polio vaccine; Sex difference

Indexed keywords

BCG VACCINE; ORAL POLIOMYELITIS VACCINE; PLACEBO; RETINOL;

ARTICLE; BCG VACCINATION; BIRTH; CHILD; CLINICAL ASSESSMENT; CLINICAL OBSERVATION; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HAZARD RATIO; HUMAN; IMMUNITY; INFANT; INFANT MORTALITY; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; MULTICENTER STUDY; POISSON DISTRIBUTION; POLIOMYELITIS; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCAR; SEX DIFFERENCE; TUBERCULOSIS; VITAMIN SUPPLEMENTATION;

BCG VACCINE; FEMALE; GUINEA-BISSAU; HUMANS; INFANT; INFANT MORTALITY; INFANT, NEWBORN; MALE; POISSON DISTRIBUTION; POLIOVIRUS VACCINE, ORAL; PROPORTIONAL HAZARDS MODELS; SEX FACTORS; VACCINATION; VITAMIN A;

EID: 84867467104     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.08.055     Document Type: Article

References (31)

1. Halsey N., Galazka A. The efficacy of DPT and oral poliomyelitis immunization schedules initiated from birth to 12 weeks of age. Bull World Health Organ 1985, 1151-1169.
2. Polio vaccines and polio immunization in the pre-eradication era: WHO position paper. Wkly Epidemiol Rec 2010 June;85(23):213-28.
3. Aaby P., Jensen H., Garly M.L., Balé C., Martins C., Lisse I. Routine vaccinations and child survival in a war situation with high mortality: effect of gender. Vaccine 2002, 21(1):15-20.
4. Aaby P., Jensen H., Rodrigues A., Garly M.L., Benn C.S., Lisse I.M., et al. Divergent female-male mortality ratios associated with different routine vaccinations among female-male twin pairs. Int J Epidemiol 2004, 33(April (2)):367.
5. Aaby P., Jensen H., Walraven G. Age-specific changes in the female-male mortality ratio related to the pattern of vaccinations: an observational study from rural Gambia. Vaccine 2006, 24(May (22)):4701-4708.
6. Aaby P., Vessari H., Nielsen J., Maleta K., Benn C.S., Jensen H., et al. Sex differential effects of routine immunizations and childhood survival in rural Malawi. Pediatr Infect Dis J 2006, 25(August (8)):721.
7. Aaby P., Garly M.L., Balé C., Martins C., Jensen H., Lisse I., et al. Survival of previously measles-vaccinated and measles-unvaccinated children in an emergency situation: an unplanned study. Pediatr Infect Dis J 2003, 22(September (9)):798.
8. Aaby P., Samb B., Simondon F., Seck A.M.C., Knudsen K., Whittle H. Non-specific beneficial effect of measles immunisation: analysis of mortality studies from developing countries. BMJ 1995, 311(August (7003)):481-485.
9. Aaby P., Bhuiya A., Nahar L., Knudsen K., de Francisco A., Strong M. The survival benefit of measles immunization may not be explained entirely by the prevention of measles disease: a community study from rural Bangladesh. Int J Epidemiol 2003, 32(February (1)):106-115.
10. Aaby P., Martins C.L., Garly M.L., Balé C., Andersen A., Rodrigues A., et al. Non-specific effects of standard measles vaccine at 4.5 and 9 months of age on childhood mortality: randomised controlled trial. BMJ 2010, (January):341.
11. Aaby P., Roth A., Ravn H., Napirna B.M., Rodrigues A., Lisse I.M., et al. Randomized trial of BCG vaccination at birth to low-birth-weight children: beneficial nonspecific effects in the neonatal period?. J Infect Dis 2011, 204(July (2)):245-252.
12. Biering-Sørensen S., Aaby P., Napirna B.M., Roth A., Ravn H., Rodrigues A., et al. Small randomized trial among low-birth-weight children of Bacillus Calmette-Guérin vaccination at first health center contact. Pediatr Infect Dis J 2012, 31(March (3)):306-308.
13. Roth A., Jensen H., Garly M.L., Djana Q., Martins C.L., Sodemann M., et al. Low birth weight infants and Calmette-Guérin bacillus vaccination at birth: community study from Guinea-Bissau. Pediatr Infect Dis J 2004, 23(June (6)):544.
14. Aaby P., Jensen H., Gomes J., Fernandes M., Lisse I.M. The introduction of diphtheria-tetanus-pertussis vaccine and child mortality in rural Guinea-Bissau: an observational study. Int J Epidemiol 2004, 33(2):374.
15. Aaby P., Ravn H., Roth A., Rodrigues A., Lisse I.M., Diness B.R., et al. Early diphtheria-tetanus-pertussis vaccination associated with higher female mortality and no difference in male mortality in a cohort of low birthweight children: an observational study within a randomised trial. Arch Dis Child 2012, 97(August (8)):685-691.
16. Aaby P., Benn C., Nielsen J., Lisse I.M., Rodrigues A., Ravn H. Testing the hypothesis that diphtheria-tetanus-pertussis vaccine has negative non-specific and sex-differential effects on child survival in high-mortality countries. BMJ Open 2012, 2:e000707. 10.1136/bmjopen-2011-000707.
17. Aaby P., Hedegaard K., Sodemann M., Nhante E., Veirum J.E., Jakobsen M., et al. Childhood mortality after oral polio immunisation campaign in Guinea-Bissau. Vaccine 2005, 23(February (14)):1746-1751.
18. Benn C.S., Fisker A.B., Rodrigues A., Ravn H., Sartono E., Whittle H., et al. Sex-differential effect on infant mortality of oral polio vaccine administered with BCG at birth in Guinea-Bissau. A natural experiment. PLoS ONE 2008, 3(December (12)):e4056.
19. Sartono E., Lisse I.M., Terveer E.M., van de Sande P.J.M., Whittle H., Fisker A.B., et al. Oral polio vaccine influences the immune response to BCG vaccination. A natural experiment. PLoS ONE 2010, 5(May (5)):e10328.
20. Benn C.S., Fisker A.B., Napirna B.M., Roth A., Diness B.R., Lausch K.R., et al. Vitamin A supplementation and BCG vaccination at birth in low birthweight neonates: two by two factorial randomised controlled trial. BMJ 2010, (January):340.
21. Bouros D., Zeros G., Panaretos C., Vassilatos C., Siafakas N. Palpation vs pen method for the measurement of skin tuberculin reaction (Mantoux test). Chest 1991, 99(February (2)):416-419.
22. Garly M.L., Balé C., Martins C.L., Baldé M.A., Hedegaard K.L., Whittle H.C., et al. BCG vaccination among West African infants is associated with less anergy to tuberculin and diphtheria-tetanus antigens. Vaccine 2001, 20(November (3-4)):468.
23. Greenland S. Modeling and variable selection in epidemiologic analysis. Am J Public Health 1989, 79(March (3)):340.
24. Barros A.J., Hirakata V.N. Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio. BMC Med Res Methodol 2003, 3(October):21.
25. Romagnani S. Induction of TH1 and TH2 responses: a key role for the 'natural' immune response?. Immunol Today 1992, 13(October (10)):379.
26. Huber S.A., Pfaeffle B. Differential Th1 and Th2 cell responses in male and female BALB/c mice infected with coxsackievirus group B type 3. J Virol 1994, 68(August (8)):5126.
27. Mullooly J.P., Schuler R., Mesa J., Drew L., DeStefano F. Wheezing lower respiratory disease and vaccination of premature infants. Vaccine 2011, 29(October (44)):7611-7617.
28. Seppälä E., Viskari H., Hoppu S., Honkanen H., Huhtala H., Simell O., et al. Viral interference induced by live attenuated virus vaccine (OPV) can prevent otitis media. Vaccine 2011, 29(November (47)):8615-8618.
29. Global Polio Eradication Initiative. Global Polio Eradication Initiative Strategic Plan 2010-2012. 2010.
30. Bonnet M.C., Dutta A. World wide experience with inactivated poliovirus vaccine. Vaccine 2008, 26(39):4978-4983.
31. Aaby P., Garly M.L., Nielsen J., Ravn H., Martins C., Balé C., et al. Increased female-male mortality ratio associated with inactivated polio and diphtheria-tetanus-pertussis vaccines: observations from vaccination trials in Guinea-Bissau. Pediatr Infect Dis J 2007, 26(January (3)):247.